TickerKhojComparison · NSE · data 2026-11-02
Innova Captab Limited vs Supriya Lifescience Limited
In plain words
Size: Supriya Lifescience Limited is about 1.2 times the market value of Innova Captab Limited.
Return on equity: Supriya Lifescience Limited 19.1% vs Innova Captab Limited 14%.
Profit growth over 3 years: Supriya Lifescience Limited 32.5% a year vs Innova Captab Limited 28.2% a year.
Debt to equity: Innova Captab Limited 0.32 vs Supriya Lifescience Limited 0.
Differences in the numbers, not a recommendation of either stock.
Side by side
| INNOVACAP | SUPRIYA | |
|---|---|---|
| Price | ₹1,015.5 | ₹847.8 |
| Market cap | ₹5,900 cr | ₹6,810 cr |
| P/E | 37.2 | 34.4 |
| P/B | — | — |
| ROE | 14.0% | 19.1% |
| ROCE | 12.9% | 22.3% |
| Debt / equity | 0.32 | 0 |
| Operating margin | 12.2% | 29.7% |
| Dividend yield | 0.19% | 0.12% |
| Sales growth, 3 years (yearly) | 20.1% | 21.2% |
| Profit growth, 3 years (yearly) | 28.2% | 32.5% |
| 1-year return | 22.0% | 12.5% |
| Revenue, last 12 months | ₹1,749 cr | ₹873 cr |
| Net profit, last 12 months | ₹156 cr | ₹198 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹44 cr | ₹24 cr |
| Quarter profit vs a year earlier | +42.3% | -30.9% |
| Promoter holding | 50.90% | 68.30% |
| Health check | Strong (7.4/10) | Strong (7.3/10) |
Common questions
Which has a higher P/E, Innova Captab Limited or Supriya Lifescience Limited?
Innova Captab Limited trades at the higher P/E (37.2 against 34.4). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Supriya Lifescience Limited (19.1% against 14.0%).
Which carries more debt?
Innova Captab Limited has the higher debt-to-equity ratio (0.32 against 0).